Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Greg M Delgoffe

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Journal of STEM Outreach|March 13, 2023
Getting to YES: The Evolution of the University of Pittsburgh Medical Center Hillman Cancer Center Youth Enjoy Science (YES) AcademyJoseph C Ayoob, Richard D Boyce, Solomon Livshits, et al.
Immunity|July 28, 2019
Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8<sup>+</sup> T Cell-Derived Interferon-γChang Liu, Maria Chikina, Rahul Deshpande, et al.
The Journal of Clinical Investigation|June 29, 2018
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiationFrank P Vendetti, Pooja Karukonda, David A Clump, et al.
Cancer Immunology Research|June 27, 2019
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor CellLulu Shao, Weizhou Hou, Nicole E Scharping, et al.
Immunity|January 12, 2010
The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activationMuhammet F Gulen, Zizhen Kang, Katarzyna Bulek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 26, 2019
The Lysophosphatidylcholine Transporter MFSD2A Is Essential for CD8<sup>+</sup> Memory T Cell Maintenance and Secondary Response to InfectionAnn R Piccirillo, Eric J Hyzny, Lisa Y Beppu, et al.
Cell Reports|September 21, 2022
Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expressionNorie Sugitani, Frank P Vendetti, Andrew J Cipriano, et al.
Cancer Immunology Research|August 19, 2025
Reprogramming CD8+ T-cell branched N-glycosylation limits exhaustion, enhancing cytotoxicity and tumor killingCatarina M Azevedo, Bingxian Xie, William G Gunn, et al.
Nature Immunology|February 19, 2020
Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysisFlorian J Weisel, Steven J Mullett, Rebecca A Elsner, et al.
Cell Metabolism|January 29, 2025
Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapyAndrew T Frisch, Yiyang Wang, Bingxian Xie, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Journal of STEM Outreach|March 13, 2023
Getting to YES: The Evolution of the University of Pittsburgh Medical Center Hillman Cancer Center Youth Enjoy Science (YES) AcademyJoseph C Ayoob, Richard D Boyce, Solomon Livshits, et al.
Immunity|July 28, 2019
Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8<sup>+</sup> T Cell-Derived Interferon-γChang Liu, Maria Chikina, Rahul Deshpande, et al.
The Journal of Clinical Investigation|June 29, 2018
ATR kinase inhibitor AZD6738 potentiates CD8+ T cell-dependent antitumor activity following radiationFrank P Vendetti, Pooja Karukonda, David A Clump, et al.
Cancer Immunology Research|June 27, 2019
IRF1 Inhibits Antitumor Immunity through the Upregulation of PD-L1 in the Tumor CellLulu Shao, Weizhou Hou, Nicole E Scharping, et al.
Immunity|January 12, 2010
The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activationMuhammet F Gulen, Zizhen Kang, Katarzyna Bulek, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 26, 2019
The Lysophosphatidylcholine Transporter MFSD2A Is Essential for CD8<sup>+</sup> Memory T Cell Maintenance and Secondary Response to InfectionAnn R Piccirillo, Eric J Hyzny, Lisa Y Beppu, et al.
Cell Reports|September 21, 2022
Thymidine rescues ATR kinase inhibitor-induced deoxyuridine contamination in genomic DNA, cell death, and interferon-α/β expressionNorie Sugitani, Frank P Vendetti, Andrew J Cipriano, et al.
Cancer Immunology Research|August 19, 2025
Reprogramming CD8+ T-cell branched N-glycosylation limits exhaustion, enhancing cytotoxicity and tumor killingCatarina M Azevedo, Bingxian Xie, William G Gunn, et al.
Nature Immunology|February 19, 2020
Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysisFlorian J Weisel, Steven J Mullett, Rebecca A Elsner, et al.
Cell Metabolism|January 29, 2025
Redirecting glucose flux during in vitro expansion generates epigenetically and metabolically superior T cells for cancer immunotherapyAndrew T Frisch, Yiyang Wang, Bingxian Xie, et al.
Pageof 12